ZIMLABPharmaceuticals
Zim Laboratories Ltd — Balance Sheet
₹60.26
-0.45%
Zim Laboratories Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 4.87 Cr | 4.87 Cr | 4.87 Cr | 4.87 Cr | — |
| Share Issued | 4.87 Cr | 4.87 Cr | 4.87 Cr | 4.87 Cr | — |
| Net Debt | 110.10 Cr | 96.61 Cr | 52.99 Cr | 47.76 Cr | — |
| Total Debt | 117.68 Cr | 111.63 Cr | 62.00 Cr | 53.31 Cr | — |
| Tangible Book Value | 219.89 Cr | 216.09 Cr | 186.26 Cr | 165.19 Cr | — |
| Invested Capital | 364.29 Cr | 344.96 Cr | 259.76 Cr | 226.89 Cr | — |
| Working Capital | 64.94 Cr | 68.22 Cr | 80.16 Cr | 66.23 Cr | — |
| Net Tangible Assets | 219.89 Cr | 216.09 Cr | 186.26 Cr | 165.19 Cr | — |
| Capital Lease Obligations | 5.63 Cr | 5.42 Cr | 2.59 Cr | 2.13 Cr | — |
| Common Stock Equity | 252.24 Cr | 238.75 Cr | 200.35 Cr | 175.71 Cr | — |
| Total Capitalization | 292.54 Cr | 274.35 Cr | 224.97 Cr | 194.63 Cr | — |
| Total Equity Gross Minority Interest | 252.24 Cr | 238.75 Cr | 200.35 Cr | 175.71 Cr | — |
| Minority Interest | 5000.00 | 3000.00 | 0.00 | — | — |
| Stockholders Equity | 252.24 Cr | 238.75 Cr | 200.35 Cr | 175.71 Cr | — |
| Other Equity Interest | 22.76 Cr | 21.40 Cr | 151.62 Cr | — | 144.52 Cr |
| Retained Earnings | 169.06 Cr | 157.43 Cr | 140.57 Cr | 116.59 Cr | — |
| Additional Paid In Capital | 8.03 Cr | 8.03 Cr | 8.03 Cr | 40.99 Cr | — |
| Capital Stock | 48.73 Cr | 48.73 Cr | 48.73 Cr | 16.24 Cr | — |
| Common Stock | 48.73 Cr | 48.73 Cr | 48.73 Cr | 16.24 Cr | — |
| Total Liabilities Net Minority Interest | 219.79 Cr | 208.08 Cr | 141.23 Cr | 165.92 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 53.42 Cr | 48.65 Cr | 30.45 Cr | 20.01 Cr | — |
| Non Current Deferred Taxes Liabilities | 11.05 Cr | 10.10 Cr | 4.80 Cr | 0.36 Cr | — |
| Long Term Debt And Capital Lease Obligation | 42.37 Cr | 38.55 Cr | 25.64 Cr | 19.65 Cr | — |
| Long Term Capital Lease Obligation | 2.07 Cr | 2.95 Cr | 1.02 Cr | 0.72 Cr | — |
| Long Term Debt | 40.30 Cr | 35.60 Cr | 24.62 Cr | 18.92 Cr | — |
| Current Liabilities | 166.36 Cr | 159.43 Cr | 110.79 Cr | 145.91 Cr | — |
| Other Current Liabilities | 0.59 Cr | 0.07 Cr | 0.02 Cr | 0.04 Cr | — |
| Current Debt And Capital Lease Obligation | 75.31 Cr | 73.08 Cr | 36.36 Cr | 33.67 Cr | — |
| Current Capital Lease Obligation | 3.56 Cr | 2.47 Cr | 1.57 Cr | 1.41 Cr | — |
| Current Debt | 71.75 Cr | 70.61 Cr | 34.79 Cr | 32.26 Cr | — |
| Pensionand Other Post Retirement Benefit Plans Current | 10.49 Cr | 5.65 Cr | 6.14 Cr | 3.55 Cr | — |
| Current Provisions | 0.68 Cr | 0.80 Cr | 0.59 Cr | — | 1.40 Cr |
| Payables | 77.01 Cr | 70.69 Cr | 63.48 Cr | 84.17 Cr | — |
| Other Payable | 7.41 Cr | 8.16 Cr | 5.05 Cr | 2.84 Cr | — |
| Dividends Payable | 0.09 Cr | 0.15 Cr | 0.20 Cr | 0.26 Cr | — |
| Total Tax Payable | 2.92 Cr | — | 0.00 | — | — |
| Accounts Payable | 69.51 Cr | 62.38 Cr | 58.24 Cr | 81.07 Cr | — |
| Total Assets | 472.02 Cr | 446.82 Cr | 341.58 Cr | 341.63 Cr | — |
| Total Non Current Assets | 240.72 Cr | 219.17 Cr | 150.63 Cr | 129.49 Cr | — |
| Other Non Current Assets | 3.85 Cr | 11.36 Cr | 11.79 Cr | — | 5.66 Cr |
| Non Current Prepaid Assets | 4.89 Cr | 15.23 Cr | 14.01 Cr | 10.50 Cr | — |
| Investmentin Financial Assets | 0.05 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | — |
| Held To Maturity Securities | 0.00 | 15000.00 | 15000.00 | 15000.00 | — |
| Available For Sale Securities | 1.08 Cr | 0.84 Cr | 0.97 Cr | — | 2.75 Cr |
| Financial Assets Designatedas Fair Value Through Profitor Loss Total | 0.05 Cr | 0.05 Cr | 0.05 Cr | 0.05 Cr | — |
| Goodwill And Other Intangible Assets | 32.34 Cr | 22.66 Cr | 14.09 Cr | 10.52 Cr | — |
| Other Intangible Assets | 32.17 Cr | 22.49 Cr | 13.92 Cr | 10.35 Cr | — |
| Goodwill | 0.17 Cr | 0.17 Cr | 0.17 Cr | 0.17 Cr | — |
| Net PPE | 202.40 Cr | 180.45 Cr | 121.56 Cr | 106.86 Cr | — |
| Accumulated Depreciation | -91.53 Cr | -87.31 Cr | -74.42 Cr | -63.01 Cr | — |
| Gross PPE | 293.93 Cr | 267.76 Cr | 195.98 Cr | 169.87 Cr | — |
| Construction In Progress | 44.05 Cr | 23.52 Cr | 17.84 Cr | 5.10 Cr | — |
| Other Properties | 13.91 Cr | 18.61 Cr | 12.27 Cr | 8.82 Cr | — |
| Machinery Furniture Equipment | 133.23 Cr | 130.56 Cr | 99.47 Cr | 92.75 Cr | — |
| Buildings And Improvements | 81.99 Cr | 79.00 Cr | 50.32 Cr | 47.14 Cr | — |
| Land And Improvements | 20.74 Cr | 16.07 Cr | 16.07 Cr | 16.07 Cr | — |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Current Assets | 231.31 Cr | 227.65 Cr | 190.95 Cr | 212.14 Cr | — |
| Other Current Assets | 0.55 Cr | 0.33 Cr | 0.67 Cr | 0.39 Cr | — |
| Assets Held For Sale Current | 0.00 | 0.06 Cr | 0.07 Cr | 0.00 | — |
| Restricted Cash | 0.71 Cr | 1.11 Cr | 1.17 Cr | 1.77 Cr | — |
| Prepaid Assets | 34.56 Cr | 31.73 Cr | 30.13 Cr | 33.47 Cr | — |
| Inventory | 86.47 Cr | 81.26 Cr | 53.71 Cr | 75.28 Cr | — |
| Finished Goods | 20.22 Cr | 26.97 Cr | 9.00 Cr | 18.69 Cr | — |
| Work In Process | 7.45 Cr | 1.97 Cr | 5.88 Cr | 12.66 Cr | — |
| Raw Materials | 58.79 Cr | 52.32 Cr | 38.82 Cr | 43.93 Cr | — |
| Other Receivables | 0.08 Cr | 3.36 Cr | 3.49 Cr | 8.29 Cr | — |
| Accounts Receivable | 106.92 Cr | 100.17 Cr | 95.25 Cr | 89.52 Cr | — |
| Allowance For Doubtful Accounts Receivable | -0.80 Cr | -1.52 Cr | -1.69 Cr | -0.90 Cr | — |
| Gross Accounts Receivable | 107.72 Cr | 101.68 Cr | 96.94 Cr | 90.42 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 2.01 Cr | 9.64 Cr | 6.47 Cr | 3.42 Cr | — |
| Other Short Term Investments | 0.07 Cr | 0.04 Cr | 0.05 Cr | — | 16.77 Cr |
| Cash And Cash Equivalents | 1.95 Cr | 9.60 Cr | 6.42 Cr | 3.42 Cr | — |
| Cash Financial | 1.95 Cr | 9.60 Cr | 6.42 Cr | 3.42 Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Current Deferred Taxes Liabilities | — | — | 0.00 | 2.07 Cr | 0.00 |
| Non Current Deferred Taxes Assets | — | — | — | 0.00 | 2.61 Cr |
| Other Non Current Liabilities | — | — | — | — | -0.01 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Zim Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.